Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $25.79 USD
Change Today +0.57 / 2.26%
Volume 277.0K
AEGR On Other Exchanges
As of 8:10 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Craig E. Fraser

Chief Operating Officer, Aegerion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. Craig E. Fraser has been the Chief Operating Officer of Aegerion Pharmaceuticals, Inc. since July 30, 2014. Mr. Fraser served as President of US & International and Global Supply at Aegerion Pharmaceuticals, Inc and served as its President of US Commercial & Global Manufacturing and Supply Chain since September 2012. Mr. Fraser served as President of U.S. Fraser at Aegerion Pharmaceuticals, Inc. since October 25, 2011. Before that, Mr. Fraser held several commercial ...

Read Full Background

Corporate Headquarters*

One Main Street
Cambridge, Massachusetts 02142

United States

Phone: 617-500-7867
Fax: 617-945-7968

Board Members Memberships*

There is no Board Members Memberships data available.


Slippery Rock University Of Pennsylvania

Other Affiliations*

Annual Compensation*

Total Annual Compensation$340,000

Stock Options*

All Other Compensation$5,928
Exercised Options24,500
Exercised Options Value$1,890,100
Exercisable Options39,978
Exercisable Options Value$2,185,803
Unexercisable Options88,022
Unexercisable Options Value$4,479,022
Total Value of Options$12,324,275
Total Number of Options227,500

Total Compensation*

Total Annual Cash Compensation$651,928
Total Short Term Compensation$340,000
Other Long Term Compensation$5,928
Total Calculated Compensation$1,979,767
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AEGR:US $25.79 USD +0.57


Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AEGERION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at